We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$3.98B
1-Year Est. Return
20.52%
This Fund
S&P 500
This Quarter
Est. Return
-13.27%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4B
AUM Growth
-$942M
(-19%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-4.65%
Top 10 Holdings %
Top 10 Hldgs %
60.38%
Holding
66
New
6
Increased
24
Reduced
16
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$124M |
| 2 |
Microsoft
MSFT
|
+$55.7M |
| 3 |
FMC
FMC
|
+$49.1M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$40.7M |
| 5 |
Aptiv
APTV
|
+$39.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$212M |
| 2 |
MTOR
MERITOR, Inc.
MTOR
|
+$126M |
| 3 |
Cencora
COR
|
+$116M |
| 4 |
Universal Health Services
UHS
|
+$89.7M |
| 5 |
McKesson
MCK
|
+$67.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.56% |
| 2 | Technology | 19.65% |
| 3 | Industrials | 9.92% |
| 4 | Materials | 8.09% |
| 5 | Consumer Staples | 7.69% |
Similar funds
MAM
USCWA
AI
LWCA
JSW
AS
BWA
BCP
Glenview Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Glenview Capital Management held 66 positions worth $4B, down 19% from $4.94B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Glenview Capital Management withdrew a net $186M in Q2 2022, closing 11 positions and reducing 16 holdings. Its most notable exit was Bausch Health, an estimated $212M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 49% a quarter earlier, followed by Technology and Industrials.
Against the trend, Glenview Capital Management opened a new position in Microsoft worth $52.8M.
- Glenview Capital Management's largest Q2 2022 buy was Microsoft: 205,392 shares worth $52.8M.
- Glenview Capital Management added most to Cigna in Q2 2022, an estimated $124M increase.
- Glenview Capital Management's biggest Q2 2022 reduction was McKesson, cutting an estimated $67.3M.
- Glenview Capital Management fully exited Bausch Health in Q2 2022, selling an estimated $212M.
- Glenview Capital Management's ten largest holdings make up 60% of its $4B portfolio in Q2 2022.
- Glenview Capital Management opened 6 new positions and closed 11 in Q2 2022.
- Glenview Capital Management's portfolio value fell 19% quarter-over-quarter to $4B.
Based on Glenview Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.